comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 10:03:21 - browse：969

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Can food be medicine? And other questions about a new push

WSS

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Bacterial infection may be ‘key event’ in endometriosis, study says

Surge of respiratory disease in China has likely explanation

hotspot

comprehensive

explore

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Sports medicine is finally prioritizing gender equality

Childhood cancer progress stalls for Black, Hispanic kids: Report

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Wildfire smoke exposes gaps in outdoor worker protections

Weight loss drug costs may need more research, senator suggests

Continuity nursing helped my family in our darkest PICU moments

CRISPR pioneers react to Casgevy, first gene

explore

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

In key trial, Verve's treatment lowers cholesterol levels in patients

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Grail is spending more than ever lobbying Congress

A daunting task: navigating dual Medicare, Medicaid eligibility

Why is France rioting? What to know about the fatal police shooting of Nahel M

knowledge

hotspot

leisure time

Wikipedia